Serum Institute of India

covaxin bharat biotech

Expert Panel Changed Tack on Covaxin in One Day, Minutes Show

The Wire Staff 06/01/2021

On January 1, the Subject Expert Committee said that...

COVID-19 vaccine trial run in Srinagar

AIPSN Demands DCGI Reconsider Approvals for Covaxin and Covishield

All India People’s Science Network 06/01/2021

The government and CDSCO have together seriously undermined confidence...

FILE PHOTO: Outbreak of the coronavirus disease (COVID-19) in Rio de Janeiro

Brazil Scrambles for India-Made Vaccines to Jumpstart Inoculations

Ricardo Brito and Pedro Fonseca 06/01/2021

The scramble by Brazil's government and private sector underscored how...

Man applies finishing touches to graffiti representing a vaccine in Kolkata

Does India Want To Go China’s Way – Where Many Vaccines Exist, but Trust Doesn’t?

Oommen C. Kurian 06/01/2021

India can potentially be bracketed with Russia and China...

Ella_Poonawalla

India’s Vaccine Approvals Had One Problem. It Gave Rise To the Other Two.

Vasudevan Mukunth 05/01/2021

For the Modi government's desire to push an Indian...

FILE PHOTO: An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India, in Pune

Bharat Biotech Planning 700 Million Doses of COVID-19 Vaccine Candidate in 2021

Anuron Kumar Mitra 04/01/2021

Covaxin's emergency use approval has prompted questions from industry...

FILE PHOTO: A medic fills a syringe with COVAXIN, an Indian government-backed experimental COVID-19 vaccine, before administering it to a health worker during its trials, in Ahmedabad

DCGI’s Covaxin Verdict Forces First Vaccine Recipients To Make a Tough Call

Vasudevan Mukunth 04/01/2021

We have a situation in which at least some...